- Home
- NBIX vs RBC Comparison
NBIX vs RBC Comparison
Compare NBIX & RBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- RBC
- Stock Information
- Founded
- NBIX 1992
- RBC 1919
- Country
- NBIX United States
- RBC United States
- Employees
- NBIX N/A
- RBC N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- RBC Metal Fabrications
- Sector
- NBIX Health Care
- RBC Industrials
- Exchange
- NBIX Nasdaq
- RBC Nasdaq
- Market Cap
- NBIX 11.0B
- RBC 9.7B
- IPO Year
- NBIX 1996
- RBC 2005
- Fundamental
- Price
- NBIX $115.71
- RBC $348.93
- Analyst Decision
- NBIX Strong Buy
- RBC Buy
- Analyst Count
- NBIX 20
- RBC 8
- Target Price
- NBIX $163.20
- RBC $357.67
- AVG Volume (30 Days)
- NBIX 1.8M
- RBC 142.4K
- Earning Date
- NBIX 05-05-2025
- RBC 05-16-2025
- Dividend Yield
- NBIX N/A
- RBC N/A
- EPS Growth
- NBIX N/A
- RBC 22.03
- EPS
- NBIX 2.96
- RBC 7.30
- Revenue
- NBIX $2,412,600,000.00
- RBC $1,612,300,000.00
- Revenue This Year
- NBIX $15.36
- RBC $6.13
- Revenue Next Year
- NBIX $16.34
- RBC $8.03
- P/E Ratio
- NBIX $39.66
- RBC $48.03
- Revenue Growth
- NBIX 21.73
- RBC 4.63
- 52 Week Low
- NBIX $84.23
- RBC $260.53
- 52 Week High
- NBIX $157.98
- RBC $372.83
- Technical
- Relative Strength Index (RSI)
- NBIX 60.88
- RBC 61.92
- Support Level
- NBIX $105.45
- RBC $337.43
- Resistance Level
- NBIX $130.46
- RBC $346.02
- Average True Range (ATR)
- NBIX 4.31
- RBC 7.72
- MACD
- NBIX 1.96
- RBC 2.86
- Stochastic Oscillator
- NBIX 50.22
- RBC 87.42
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About RBC RBC Bearings Incorporated
RBC Bearings Inc is an international manufacturer and marketer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The end market is the United States of America. The company has two reportable segments: Aerospace Defense segment represents the end markets for the company's highly engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and Industrial segment represents the end markets for the company's engineered bearings and precision components used in various industrial applications. It derives maximum revenue from Industrial Segment.